Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Focal Adhesion Kinase Inhibition Contributes to Tumor Cell Survival and Motility in Neuroblastoma Patient-Derived Xenografts.
Journal: Scientific reports
Published: June 10, 2019
UAB30, A Novel Rexinoid Agonist, Decreases Stemness In Group 3 Medulloblastoma Human Cell Line Xenografts.
Journal: Translational oncology
Published: May 29, 2019
Targeting PIM Kinases Affects Maintenance of CD133 Tumor Cell Population in Hepatoblastoma.
Journal: Translational oncology
Published: September 02, 2018
Investigation of PP2A and Its Endogenous Inhibitors in Neuroblastoma Cell Survival and Tumor Growth.
Investigation of PP2A and Its Endogenous Inhibitors in Neuroblastoma Cell Survival and Tumor Growth.
Journal: Translational oncology
Published: August 04, 2018
UAB30, a novel RXR agonist, decreases tumorigenesis and leptomeningeal disease in group 3 medulloblastoma patient-derived xenografts.
Journal: Journal of neuro-oncology
Published: April 02, 2018
Targeting PIM kinase as a therapeutic strategy in human hepatoblastoma.
Journal: Oncotarget
Published: January 29, 2018
How academically productive are endocrine surgeons in the United States?
Journal: The Journal of surgical research
Published: December 26, 2017
FTY720 Decreases Tumorigenesis in Group 3 Medulloblastoma Patient-Derived Xenografts.
Journal: Scientific reports
Published: November 18, 2017
Effects of socioeconomic status on children with well-differentiated thyroid cancer.
Journal: Surgery
Published: March 01, 2017
Targeting Focal Adhesion Kinase Suppresses the Malignant Phenotype in Rhabdomyosarcoma Cells.
Journal: Translational oncology
Published: March 30, 2016
Last Updated: 09/26/2026